CoChat

Bufotenine: Toward an Understanding of Possible Psychoactive Mechanisms

McBride, Michael C. · 2000 · Journal of Psychoactive Drugs

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

A review of the neuropharmacology of the alleged hallucinogen bufotenine is presented, including recent experimental results showing activity similar to LSD and other known hallucinogens (psilocin and 5-MeO-DMT) at the purported hallucinogenic serotonin (5-HT) receptors, 5-HT2A and 5-HT2C. In addition, current reports of computer modeling of the receptors and ligand binding sites give evidence of bufotenine's ability to bind and activate these receptors. While binding and activation of the purported hallucinogenic receptors are not the full extent of the hallucinogenic signature, this evidence shows support for the rationale that the reported lack of the drug's classic hallucinogenic response in human experiments is due to poor ability to cross the blood brain barrier (BBB), not lack of activation of the appropriate brain receptors. Further evidence is reviewed that in some physiological states, some drugs with characteristics similar to bufotenine which do not normally cross the BBB, cross it and enter the brain. While direct human experimental evidence of bufotenine's hallucinogenic activity seems lacking, the above combined factors are considered, and possible explanations of bufotenine's reported psychoactivity are suggested. Additionally, updated experimental models testing the possible nature of bufotenine's hallucinogenic potential are proposed.

Overview

Integrity signals

Registry

Crossref · 10.1080/02791072.2000.10400456

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 77 references

Research works printed but not linked: 11

  1. Aghajanian G. K., 1975, Psychopharmacology Communication, 619
  2. Borne R. F., 1994, Drug Topics, 108
  3. Coe M., 1980, In the Land of the Olmec.
  4. Donnelly D., 1994, Receptor Channels, 2, 61
  5. Huang K. N., 1991, Serotonin Receptor Subtypes: Basic and Clinical Aspects.
  6. Jacob P., 1994, Hallucinogens: An Update.
  7. Peroutka S. J., 1991, Serotonin Receptor Subtypes: Basic and Clinical Aspects.
  8. Sanders-Bush E., 1994, Hallucinogens: An Update.
  9. Schultes R. E., 1990, Flesh of the Gods, The Ritual Use of Hallucinogens.
  10. Shih J. C., 1995, Psychopharmacology: The Fourth Generation of Progress.
  11. Wasson R. G., 1990, Flesh of the Gods, The Ritual Use of Hallucinogens

Cited by

See all 74

Metadata

Authors
McBride, M. C.
Affiliations
a Independent Researcher , Plano, Texas
Corresponding author
McBride, Michael C.
Venue
Journal of Psychoactive Drugs
Published
2000-09-01
Volume
32
Issue
3
Pages
321-331
ISSN
  • 0279-1072 (ISSN-L)
  • 2159-9777
OpenAlex
W2055011448
Cited by
74
References
77
Citations by year
2026: 4 · 2025: 6 · 2024: 5 · 2023: 10 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 3 · 2013: 4 · 2012: 1
FWCI
0.36
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Psychoactive Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
Keywords
bufotenine, hallucinogens, 5-HT2A receptor, 5-HT2C receptor, serotonin receptors, receptor binding, blood-brain barrier permeability, LSD, psilocin, 5-MeO-DMT
MeSH terms
Blood-Brain Barrier, Bufotenin, Humans, Psychotropic Drugs, Receptors, Serotonin, Serotonin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bufotenine: Toward an Understanding of Possible Psychoactive Mechanisms. https://app.cochat.ai/papers/10.1080/02791072.2000.10400456
The paper
McBride, M. C. (2000). Bufotenine: Toward an Understanding of Possible Psychoactive Mechanisms. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2000.10400456

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.